<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-TZA-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Tanzania, United Republic of: Targeted country assistance</narrative>
   <narrative xml:lang="FR">Tanzanie (la R&#xE9;publique-Unie de): Aide cibl&#xE9;e aux pays</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Development Partners in Consulting</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.21107.35" role="4">
   <narrative xml:lang="EN">Johns Hopkins University</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Tanzania, United Republic of</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="TZ" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="TZ" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Dodoma</narrative>
   </name>
   <administrative code="TZ" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-6.17486 35.73792</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1713481</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2428800</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2307699</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">299763</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="TZAPEF-TCA-DEVPART2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">174300</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-DEVPART (Development Partners in Consulting)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Development Partners in Consulting</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-JHU2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">195301</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">460067</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">271671</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-ROCQUE2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">93440</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">282788</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">235914</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-CHAI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">39436</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-DEVPART2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-DEVPART (Development Partners in Consulting)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Development Partners in Consulting</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-JHU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">508240</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">752924</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">376985</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-ROCQUE2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">125245</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">6000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">334152</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">285818</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">647318</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-JHU2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">310513</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">464817</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-ROCQUE2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">31851</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">14276</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">305515</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">533410</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-CHAI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">140497</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="TZAPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">159266</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-25"></transaction-date>
   <value currency="USD" value-date="2021-03-25">41897</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002905">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-29"></transaction-date>
   <value currency="USD" value-date="2021-06-29">66988</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">159142</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000557">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-26"></transaction-date>
   <value currency="USD" value-date="2019-11-26">44603</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DEVPART (Development Partners in Consulting)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Development Partners in Consulting</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">62970</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DEVPART (Development Partners in Consulting)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Development Partners in Consulting</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001168">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">66727</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DEVPART (Development Partners in Consulting)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Development Partners in Consulting</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-62970</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DEVPART (Development Partners in Consulting)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Development Partners in Consulting</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000816">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-12"></transaction-date>
   <value currency="USD" value-date="2020-03-12">61607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DEVPART (Development Partners in Consulting)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Development Partners in Consulting</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000983">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">79268</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001143">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-13566</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">78431</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001268">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">51168</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000976">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-19"></transaction-date>
   <value currency="USD" value-date="2020-03-19">49932</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-121990</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">121990</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000781">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-25"></transaction-date>
   <value currency="USD" value-date="2021-02-25">106718</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001154">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">53534</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">-84577</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">84577</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001325">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">17116</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001325">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">176065</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001900">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-07"></transaction-date>
   <value currency="USD" value-date="2021-10-07">11438</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003100">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-07"></transaction-date>
   <value currency="USD" value-date="2021-10-07">16791</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-84577</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">84577</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000143">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-14"></transaction-date>
   <value currency="USD" value-date="2022-01-14">99507</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001025">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">43076</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001191">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">53774</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001323">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-57882</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003841">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">168188</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006898">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-103578</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006896">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-32305</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006897">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-32305</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006901">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">103578</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006899">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">32305</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006900">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">32305</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">126616</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001273">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-1171</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001269">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">103578</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001258">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">23887</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000842">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-16"></transaction-date>
   <value currency="USD" value-date="2020-03-16">40627</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000972">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-19"></transaction-date>
   <value currency="USD" value-date="2020-03-19">64614</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001498">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">69644</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003015">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-22"></transaction-date>
   <value currency="USD" value-date="2020-07-22">115811</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003146">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-19"></transaction-date>
   <value currency="USD" value-date="2020-08-19">28778</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005461">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-15"></transaction-date>
   <value currency="USD" value-date="2020-12-15">3561</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005621">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">132911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-496</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">496</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000053">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-08"></transaction-date>
   <value currency="USD" value-date="2021-02-08">159442</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001725">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-20"></transaction-date>
   <value currency="USD" value-date="2021-04-20">24239</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001943">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">5954</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003496">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-27"></transaction-date>
   <value currency="USD" value-date="2021-07-27">31573</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005143">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-12"></transaction-date>
   <value currency="USD" value-date="2021-10-12">25942</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006232">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-17"></transaction-date>
   <value currency="USD" value-date="2021-11-17">18996</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007357">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">129558</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007356">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">38500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-14136</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">14136</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000955">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-03-07"></transaction-date>
   <value currency="USD" value-date="2022-03-07">53628</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001192">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">149874</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001324">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-105621</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000233">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">227418</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-227418</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">227418</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000164">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">143272</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001227">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">38105</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001355">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-7595</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006991">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">18697</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000803">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-10"></transaction-date>
   <value currency="USD" value-date="2019-12-10">31045</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002014">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-18"></transaction-date>
   <value currency="USD" value-date="2020-05-18">28880</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002793">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-07"></transaction-date>
   <value currency="USD" value-date="2020-07-07">27300</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004326">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-27"></transaction-date>
   <value currency="USD" value-date="2020-10-27">2299</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004326">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-27"></transaction-date>
   <value currency="USD" value-date="2020-10-27">36000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005141">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-08"></transaction-date>
   <value currency="USD" value-date="2020-12-08">13400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005141">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-08"></transaction-date>
   <value currency="USD" value-date="2020-12-08">3161</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700005409">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-49399</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-5405</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700005409">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">49399</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">5405</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001240">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-25"></transaction-date>
   <value currency="USD" value-date="2021-03-25">13174</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001240">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-25"></transaction-date>
   <value currency="USD" value-date="2021-03-25">8800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003403">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-20"></transaction-date>
   <value currency="USD" value-date="2021-07-20">11000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ROCQUE</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-2276</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">2276</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">1350</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">6225</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">1500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">1950</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000912">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">282787</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">281880</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">52272</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">249355</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004709">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">56160</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000913">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">235914</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">235828</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">49990</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">249967</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-19"></transaction-date>
   <value currency="USD" value-date="2021-10-19">283443</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-tanzania-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Tanzania 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-tanzania-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Tanzania 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-tanzania-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Tanzania 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-tanzania-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Tanzania 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-tanzania-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Tanzania 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-tanzania-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Tanzania 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-tanzania-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Tanzania 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-tanzania-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Tanzania 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-TZA" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">WMS Quarterly Stock Receipt, Stock Verification and Distribution Reports for duration of TCA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support use of WMS and Complete transition of Systems">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">1. Orientation and OJT on new features (through TWG and other Users Meetings) is completed
2. Advocacy for resources to sustain EIS (in meetings involving IVD and MOH leadership) to be done in July</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support use of WMS and Complete transition of Systems">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">WMS issue vouchers for quarterly requisitions have more than 90% consistency of data when compared to MSD invoices.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% Data from Zanzibar DHIS2 captured in VIMS by end of TCA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capture of Zanzibar Immunization and supply chain data in VIMS">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">1. Rollout of VIMS at national, zonal and council levels is completed (Routine Immunization, Stock &amp; CCE management)
2. VIMS-DHIS2 integration to capture facility data to be completed in July 2021
3. Supervision in poor performing regions and districts to be completed in June 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Reports for the Data Use Activities implemented in 2020 Annual Workplan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to IVD and PORALG in monitoring and Implementation of DQIP activities">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">1. Support data review meetings through DIMP</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to IVD and PORALG in monitoring and Implementation of DQIP activities">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Completed, see attached documents.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of targeted&#xA0;Regions trained on EIS as planned in HSS2 for Y1</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support scale up of Electronic Immunization Systems">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">1. Support scale up of TImR through paperless implementation in 2 regions, Mwanza &amp; Kilimanjaro</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support scale up of Electronic Immunization Systems">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">1. Support scale up of TImR through paperless implementation in 2 regions, Mwanza &amp; Kilimanjaro</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support scale up of Electronic Immunization Systems">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">The Tanzania Immunization Registry(TImR) is in 3,748 health facilities, in 15 regions-- Tanga, Arusha, Kilimanjaro, Dodoma, Geita, Morogoro, Njombe,Mwanza, Dar es Salaam, Lindi, Mtwara, Kigoma, Ruvuma, Katavi, and Rukwa regions.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of Data synchronized between TImR -VIMS- DHIS2 by end of TCA project</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the integration of systems">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">1. VIMS-TImR ? The integration was completed through OpenHIM
2. VIMS-DHIS2 ? On going activity. Data elements have been identified and a concept map between VIMS and DHIS2 was created.
3. VIMS-RTM single sign-on integration is completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.Assessment of VIMS in comparison with Gavi LMIS TSS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance and Deploy">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">It was partially done and to be completed in July 2021 by involving VIMS users</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.Migration of data and hosting of VIMS WMS servers by MOHCDGEC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Transfer of ownership to operate and maintain">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">VIMS was successfully installed and tested in IVD servers. IVD had planned to purchase another server with higher specs and employ system admin and developers who will work closely with JSI to clone VIMS data to the new servers.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Zanzibar IVD Transitions from use of DVDMT</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capture of Zanzibar Immunization and supply chain data in VIMS">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capture of Zanzibar Immunization and supply chain data in VIMS">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least two (2) more regions make transition to paperless following implementation of EIS by November 2022</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct high level Advocacy meetings for transitioning to paperless following implementation of Electronic Immunization System (EIS)">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Additional two (2) regions for switching to paperless identified during the annual review meeting. Actual shift to paperless of the planned regions is Q1 of the year 2022
Challenge:
1. Delay in procurement of tablets that were required for the regions to shift from using paper work to electronic</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least one (1) region make transition to paperless following implementation of EIS by June 2021</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct high level Advocacy meetings for transitioning to paperless following implementation of Electronic Immunization System (EIS)">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. Two (2) regions undergone training to switch from using paper to Electronic Immunization System (EIS). Implementation of full EIS commenced in June 1st 2021.
Achievement:
1. Two (2) more regions made transition to paperless (Mwanza and Kilimanjaro)
Challenges:
1. Availability of tablets for EIS whereby there is a delay in procurement process</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&quot;VIMS WMS Data used by IVD for planning and continuous improvement
? Migration of data and Hosting of VIMS WMS servers by MOHCDGEC
? System Support tools&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Transfer of Ownership to Operate and maintain">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Data use of WMS and complete transition is completed, IVD are using VIMS WMS Stock status report extracted every week. Users have been created according to their roles and rights; 1. VIMS was successfully installed and tested in IVD servers. IVD had planned to purchase another server with higher specs and employ system admin and developers who will work closely with JSI to clone VIMS data to the new servers; 1. Development of WMS and VIMS user support manuals for both mainland and Zanzibar</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5 low performing regions achieving quality benchmarks (distribution completeness &amp; updated ledgers) in preceding 6 months;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="7.	Support Effective Vaccine Management Assessments (EVMA) preparation and implementation">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to COVID-19 priority, the EVMA has been scheduled for December 5th - 19th 2021 by IVD. Our team will participate in the preparation for the assessment and assist in the data collection and analysis.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">LTWG meetings convened and demonstrated to be using EIS data regularly in past 6 months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="6.	Support National level in supply chain monitoring through data use (On job training and supporting Logistics TWG sub-committee meetings)">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to competing priorities, the LTWG meetings were not conducted as planned. Meetings are tentatively scheduled for November, December, and January. We will continue to support through the NCE.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Increase in reporting through RTM and TImR in 5 low performing regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.	Monitoring and Maintenance visits to support RTM and TImR use in low performing regions">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">In the process of increasing reporting rate through RTM and TImR in 5 low performing regions, the team participated in monitoring and maintenance field activities in 4 regions, including Rukwa, Katavi, Kilimanjaro and Mwanza. 1 region (Mtwara region) to be visited in December 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5 low performing regions trained in triangulating stock, CCE and performance data to prepare monthly needs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.	Capacity building for subnational levels in forecasting and triangulating stock and vaccination data in VIMS (by contributing to Mid-Level Manager training, New comers training, CCE Technician training and development of immunization mentorship packages)">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">New immunization staffs including DIVOs and RIVOs were included in this Vaccine Management and technologies orientation workshop which took place in Dodoma for 10days in November 2021.Other HSS activities were not implemented due to commitment to COVID 19 acceleration plan. In the TWG meeting held November 2021, it was agreed to integrate Routine Immunization activities with COVID 19 second phase plans. IVD will also revisit their annual work plan and ensure Partners&apos; activities will be integrated.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data improvement field activity implemented in 5 low performing Regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.	Support EIS data quality improvement at national and subnational levels. JSI staff participation and co-facilitation in Immunization performance review session at subnational levels, districts immunization performance evaluation meetings (EPI parliament), Immunization Technical Working Group (TWG) meetings, ICC and Annual Immunization Evaluation meeting as planned in IVD annual plan">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Not all immunization performance evaluation meetings were conducted as planned in the IVD annual plan. We will continue to support through the NCE.
The team has participated in data improvement field activities to improve consistency of data in VIMS, RTM, DHIS2 and TImR in total number 5 low performing regions.
4 regions have been visited, including Rukwa, Katavi, Kilimanjaro and Mwanza. 1 region (Mtwara region) is to be visited in December 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documentation of lessons learnt from efforts to improve consistency of data in VIMS, RTM, DHIS2 and TImR in 5 low performing regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	Support IVD in monitoring and troubleshooting EIS integration">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">The team has documented lessons learnt from efforts to improve the consistency of data in VIMS, RTM, DHIS2 and TImR in 5 low performing regions. The IVD system review - Proposal for resolution was well documented showing action plans and timeline.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">WMS Quarterly Stock Receipt, Stock Verification and Distribution Reports for duration of TCA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support use of WMS and Complete transition of Systems with WMS systems utilised for managing all vaccines">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">WMS issue vouchers for quarterly requisitions have more than 90% consistency of data when compared to MSD invoices.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&quot;? An enhanced WMS module supporting all features defined by functional requirement documents 
? Assessment of VIMS in comparison with Gavi LMIS TSS
? SOPs and training curriculum (for Users, Administrator, Software Development Support)&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Enhance and Deploy">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">WMS module was implemented successfully, following up on making improvements and system decoration</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Zero Dose Custom Reports implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Designing decision support tools to support reaching of zero dose children. Software developers to enhance VIMS based on requirements from users, IVD and partners in efforts to reach zero dose children">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">We have enhanced VIMS custom reports to support efforts to reach zero dose children.
We are currently seeking more feedback from users, IVD and partners to finalize. We will continue to support through the NCE.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of Data synchronized between TImR -VIMS- DHIS2 by end of TCA project</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the integration of data systems by end of TCA project">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">duplicate milestone</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implementation of agreed strategies in five urban councils</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Field test key strategies in 3 major cities of Tanzania">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to COVID19 pandemic we were unable to start the actual implementation i.e decommissioning process in the field and implementation of the strategies for urban immunisation until Early Feb, 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Written lesson learnt document for scale up of strategies for urban immunization in Tanzania</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To document lesson learnt and prepare for national scale">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to COVID19 pandemic we were unable to start the actual implementation i.e decommissioning process in the field and implementation of the strategies for urban immunisation until Early Feb, 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Zero-dose assessment report for targeted urban areas.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Generate evidence on status of urban immunization (including DPT1)">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Generate evidence on status of urban immunization (including DPT1)">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Urban immunization maps developed for all target districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strategize targeted interventions for transforming urban immunization">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to COVID19 pandemic we were unable to start the actual implementation i.e decommissioning process in the field and implementation of the strategies for urban immunisation until Early Feb, 2022</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strategize targeted interventions for transforming urban immunization">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Lessons documented and shared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To document lessons learnt for Tanzania and other countries">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to COVID19 pandemic we were unable to start the actual implementation i.e decommissioning process in the field and implementation of the strategies for urban immunisation until Early Feb, 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of the obsolete CCE equipment in the focused regions decommissioned</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To facilitate Implementation of decommissioning process in selected regions">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to COVID19 pandemic we were unable to start the actual implementation i.e decommissioning process in the field and implementation of the strategies for urban immunisation until Early Feb, 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A costed decommissioning plan and roadmap costed for second batch of CCEOP by June 2022</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To facilitate Preparation of decommissioning of the second batch of CCEOP">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to COVID19 pandemic we were unable to start the actual implementation i.e decommissioning process in the field and implementation of the strategies for urban immunisation until Early Feb, 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on key players and existing processes/policies ? (landscape analysis) March 2021 Inventory of obsolete CCE conducted and key stakeholders identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducting obsolete equipment situation analysis and identification of key stakeholders">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">CCE specific decommissioning guidelines/SOPs developed and documents validated with stakeholder (IVD &amp; MoH)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Developing guidelines and Standard operating Procedures for CCEOP decommissioning">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on key players and existing processes/policies ? (landscape analysis) March 2021


Inventory of obsolete CCE conducted and key stakeholders identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducting obsolete equipment situation analysis and identification of key stakeholders">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Costed CCE decommissioning plan and roadmap developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop solid plan and roadmap for decommissioning">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Due to COVID19 pandemic we were unable to start the actual implementation i.e decommissioning process in the field and implementation of the strategies for urban immunisation until Early Feb, 2022</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop solid plan and roadmap for decommissioning">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Equity Assessment to identify gap in reaching communities for immunization services following COVID 19 outbreak in 2020">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Equity Assessment to inform service delivery approach is planned for the Q1 for the year 2022
Challenge:
Delay in the implementation process due to COVID 19 pandemic and response vaccination that pre-occupied government and partners availability</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 25% of Zero Dose children are identified and vaccinated based on the estimate

2. At least one (1) more additional data review meeting conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support management and coordination of EPI Program in Zanzibar so as to improve immunization service delivery and increase coverage, and improve data management The consultant will be embedeed in EPI team to ensure skills transfer to EPI team.">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Implementing partner for identification of zero dose children identified. Tools and SOP for the identification of Zero dose children identification completed. Funds disbursement to the region completed. Field work Implementation is ongoing
Challenge:
The outbreak of COVID 19 and response vaccination resulted in diversion of focus to response for routine vaccine services by the government and implementing partner. This has has resulted in delay of the partner implementation of identification of zero dose children for routine immunization</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and approaches developed to improve and sustain quality and safety of immunisation services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct high level Advocacy meetings for integration of Immunization, Nutrition and RMNCHA Service to ensure integrated service delivery">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Internal meeting conducted for integration of Immunization and nutrition at UNICEF side. Draft Guideline for Village Health and Nutrition Days completed that integrate immunization services. Government involvement for advocacy planned for the year 2022
Challenge:
Competing activities of the IVD program that resulted in delay in conducting advocacy meeting for integration of immunization and nutrition. these competing activities consumed the IVD program time and human resource and they include (COVID 19 response vaccination, Comprehensive IVD review and IVD strategic plan development)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Reach Every Child tools upated to include identification of Zero Dose children and integrating other child services like HIV, nutrition and malaria 

2. At least one data review meeting conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support management and coordination of EPI Program in Zanzibar so as to improve immunization service delivery and increase coverage, and improve data management The consultant will be embedeed in EPI team to ensure skills transfer to EPI team.">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. Immunization specialist to support management and coordination of immunization program in Zanzibar is in place
2. Tools and SOP for identification of zero dose children develop. Presentation of the tools and SOP to the immunization technical working group meeting done
Key achievement:
Availability of immunization specialist to support Zanzibar</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap for improved integration of EPI with other PHC services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct high level Advocacy meetings for integration of Immunization, Nutrition and RMNCHA Service to ensure integrated service delivery">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. Internal meeting for integration of Immunization and Nutrition services conducted. Agreed initial area of integration identified (During Village Health and Nutrition Days and during Child Health and Nutrition Months
2. Guideline for the Village Health and Nutrition Days updated to integrate immunization services
2. Draft concept note for integration of nutrition and immunization using Community Health Workers developed
Achievements:
1. Updated Village Health and Nutrition Days to integrate immunization
2. One (1) Internal meeting with Nutrition conducted
Challenges:
1. Availability of nutrition commodities (Vit A and Mebendazole)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Equity Assessment to identify gap in reaching communities for immunization services following COVID 19 outbreak in 2020">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Equity Assessment to inform service delivery approach is planned for the Q1 for the year 2022
Challenge:
Delay in the implementation process due to COVID 19 pandemic and response vaccination that pre-occupied government and partners availability</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Equity Assessment to identify gap in reaching communities for immunization services following COVID 19 outbreak in 2020">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. Meeting with MoH to discuss and define the assessment of Equity conducted. Agreed on the method of assessment 
Achievements:
1. Involvement of the MoH through initial kick-off meeting of planning for equity assessment</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Copies of Tanzania immunization policy guideline available at different levels of the program and used to inform program implementation.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop country immunization policy to guide the ever expanding immunization program, intorduction of new vaccines and involvement of partners in order to sustain the gains and ensure adequate resource mobilization - TA cnsultant to be embedded with IVD for at least 50% of the time">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress: 
1. Immunization Policy Guideline Developed and completed. Policy guideline presented and approved by the TWG and ICC. Policy guideline under processing for signature by the MoH before dissemination to subnational levels
Key achievement:
Finalization and Endorsement of the immunization policy by TWG and ICC
Major Challenges: 
1. Competing activities of the immunization program whereby the program was developing the national immunization strategy that consumed staff and time 
2. The outbreak of COVID 19 resulted in a diversion of focus to the response to COVID 19.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop country immunization policy to guide the ever expanding immunization program, intorduction of new vaccines and involvement of partners in order to sustain the gains and ensure adequate resource mobilization - TA cnsultant to be embedded with IVD for at least 50% of the time">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress: 
1. Immunization Policy Guideline Developed and completed. Policy guideline presented and approved by the TWG and ICC. Policy guideline under processing for signature by the MoH before dissemination to subnational levels
Key achievement:
Finalization and Endorsement of the immunization policy by TWG and ICC
Major Challenges: 
1. Competing activities of the immunization program whereby the program was developing the national immunization strategy that consumed staff and time 
2. The outbreak of COVID 19 resulted in a diversion of focus to the response to COVID 19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Zanzibar Immunization Policy document finalized and approved by zMOH by 30th June 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Situation analysis including bottleneck assessment

Develop Zanzibar immunization policy to guide the ever expanding immunization program, intorduction of new vaccines and involvement of partners in order to sustain the gains and ensure adequate resource mobilization">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress: 
1. Zanzibar Immunization Policy Guideline Developed and completed. Policy guideline presented and approved to the Zanzibar TWG. Policy guideline under processing for approval by MoH
Key achievement:
Finalization and Endorsement of the immunization policy by Zanzibar TWG 
Major Challenges: 
2. The outbreak of COVID 19 resulted in a diversion of focus to the response to COVID 19.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Situation analysis including bottleneck assessment

Develop Zanzibar immunization policy to guide the ever expanding immunization program, intorduction of new vaccines and involvement of partners in order to sustain the gains and ensure adequate resource mobilization">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress: 
1. Zanzibar Immunization Policy Guideline Developed and completed. Policy guideline presented and approved to the Zanzibar TWG. Policy guideline under processing for approval by MoH
Key achievement:
Finalization and Endorsement of the immunization policy by Zanzibar TWG 
Major Challenges: 
2. The outbreak of COVID 19 resulted in a diversion of focus to the response to COVID 19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Number of Districts reporting DTP3 coverage below 80% reduced to less that  10%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Consultancy to support management and coordination of EPI Program in Zanzibar so as to improve immunization service delivery and increase coverage, and revitalization of Interagency Coordination Committee (ICC). The consultant will be embedeed in EPI team
to ensure skills transfer to EPI team.">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. Immunization specialist to support management of immunization program in Zanzibar is recruited and in place
2. Vaccine Information Management System (VIMS) has that will support capturing district coverage has been developed
3. Inter-Agency Coordinating Committee (ICC) for Zanzibar that will oversee the immunization program and endorse the annual district coverage data has bee established
Key Achievements:
1. Establishment of VIMS and ICC for Zanzibar
Challenges:
1. Delay in availability of funds for implementation of immunization activities by MoH due to long internal processing of releasing funds
2. The COVID 19 pandemic that resulted in restriction of field level activities</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Consultancy to support management and coordination of EPI Program in Zanzibar so as to improve immunization service delivery and increase coverage, and revitalization of Interagency Coordination Committee (ICC). The consultant will be embedeed in EPI team
to ensure skills transfer to EPI team.">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. Immunization specialist to support management of immunization program in Zanzibar is recruited and in place
2. Vaccine Information Management System (VIMS) has that will support capturing district coverage has been developed
3. Inter-Agency Coordinating Committee (ICC) for Zanzibar that will oversee the immunization program and endorse the annual district coverage data has bee established
Key Achievements:
1. Establishment of VIMS and ICC for Zanzibar
Challenges:
1. Delay in availability of funds for implementation of immunization activities by MoH due to long internal processing of releasing funds
2. The COVID 19 pandemic that resulted in restriction of field level activities</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical support provided during EVMA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Unicef Immunization Specialist to monitor implementation and provide technical support to IVD program in Tanzania mainland and Zanzibar">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1.Orientation of the national level personnel on the new EVMA tools conducted and completed
2. Preparation for the required set up of information on the tool (location file, vaccine characteristics etc.) completed
3. Plan for national Training of Trainers developed
Key Achievement:
1.Training of national personnel on new EVMA tool
2. Completion of country set up on the EVMA tool
Challenges:
1. Competing activities of the Immunization Program whereby logistics personnel were involved in developing immunization strategy.
2. Human resource challenge of the national immunization program whereby minimal number are available for EVMA activity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 50% of HSS items/CCE are procured
2. Vaccine stock is monitored and report share monthly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support supply officer salary to provide technical support in the coordination of CCEOP, HSS procurements and vaccine stock monitoring">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress: 
1. All CCEOP (100%) for year 1 have been procured and installed. For the year 2, a total of 1,514 equipment has been procured and received and 1,297 (86%) has been delivered to subnational level. Out of the total quantities received, 315 (21%) has been installed.
2. Procurement of Local Area Network (LAN) and stationaries for the IVD Mabibo Office Completed. Procurement of tablets for Electronic Immunization system is ongoing. Selection of top bidders completed and samples received. Review of the samples by MoH done. Further updating of the samples based on the MoH review is ongoing.
3. Monthly stock status has been summited to RO using the available stock visibility platforms (ViVa and VIMS)
Key achievements: 
1. Completion of procurement of CCE for year 1
2. Completion of procurement of LAN and stationaries under HSS
3. Monthly submission of vaccine stock status
Major challenges: 
1.The outbreak of COVID 19 resulted in diversion of focus to the response to COVID 19. This consumed staff time from both government and partners</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.Finalized forecast tool for 2021 by 15th Septemeber 2020
2.At least 90% of the planned HSS2 supplies planned for 2020 have been procured by December, 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Quantification of vaccines and CCE and quartely  review of the supply plan so as to ensure there are no stock out at MSD central and zones 
2. Support IVD program in planning  and implementation of the HSS2 procurements.
3. Submit monthly vaccine stock status to RO">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress: 
1. The vaccines and cold chain equipment forecast 2021 for Tanzania mainland and Zanzibar&#xA0; has been finalized, summited and under implementation. 
2. Procurement of Local Area Network (LAN) and stationaries for the IVD Mabibo Office Completed. Procurement of tablets for Electronic Immunization system is ongoing. Selection of top bidders completed and samples received. Review of the samples by MoH done. Further updating of the samples based on the MoH review is ongoing.
3. Monthly stock status has been summited to RO using the available stock visibility platforms (ViVa and VIMS)
Key achievements: 
1. Completion and use of the Forecasting tools for 2021
2. Completion of procurement of LAN and stationaries under HSS
3. Monthly submission of vaccine stock status
Major challenges: 
1.The outbreak of COVID 19 resulted in diversion of focus to the response to COVID 19. This consumed staff time from both government and partners</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Quantification of vaccines and CCE and quartely  review of the supply plan so as to ensure there are no stock out at MSD central and zones 
2. Support IVD program in planning  and implementation of the HSS2 procurements.
3. Submit monthly vaccine stock status to RO">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress: 
1. The vaccines and cold chain equipment forecast 2021 for Tanzania mainland and Zanzibar&#xA0; has been finalized, summited and under implementation. 
2. Procurement of Local Area Network (LAN) and stationaries for the IVD Mabibo Office Completed. Procurement of tablets for Electronic Immunization system is ongoing. Selection of top bidders completed and samples received. Review of the samples by MoH done. Further updating of the samples based on the MoH review is ongoing.
3. Monthly stock status has been summited to RO using the available stock visibility platforms (ViVa and VIMS)
Key achievements: 
1. Completion and use of the Forecasting tools for 2021
2. Completion of procurement of LAN and stationaries under HSS
3. Monthly submission of vaccine stock status
Major challenges: 
1.The outbreak of COVID 19 resulted in diversion of focus to the response to COVID 19. This consumed staff time from both government and partners</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Reduced vaccine wastage and improved vaccine management</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for conduction of EVMA in 2020">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1.Orientation of the national level personnel on the new EVMA tools conducted and completed
2. Preparation for the required set up of information on the tool (location file, vaccine characteristics etc.) completed
3. Plan for national Training of Trainers developed and will be conducted in July 20201
Key Achievement:
1.Training of national personnel on new EVMA tool
2. Completion of country set up on the EVMA tool
Challenges:
1. Competing activities of the Immunization Program whereby logistics personnel were involved in developing immunization strategy.
2. Human resource challenge of the national immunization program whereby minimal number are available for EVMA</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for conduction of EVMA in 2020">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1.Orientation of the national level personnel on the new EVMA tools conducted and completed
2. Preparation for the required set up of information on the tool (location file, vaccine characteristics etc.) completed
3. Plan for national Training of Trainers developed and will be conducted in July 20201
Key Achievement:
1.Training of national personnel on new EVMA tool
2. Completion of country set up on the EVMA tool
Challenges:
1. Competing activities of the Immunization Program whereby logistics personnel were involved in developing immunization strategy.
2. Human resource challenge of the national immunization program whereby minimal number are available for EVMA</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for conduction of EVMA in 2020">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Training of Trainers on EVM 2 completed. Plan for subnational training is ongoing and will be completed in December 2021. Fund disbursement is ongoing. Invitation of assessors and trainers completed. Sample size selected for EVMA completed
Challenge:
Delay due to COVID 19 pandemic and response vaccination that resulted in delay training and field work by assessors</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVMA improvement plan developed and costed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support for conduction of EVMA in 2020">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1.Orientation of the national level personnel on the new EVMA tools conducted and completed
2. Preparation for the required set up of information on the tool (location file, vaccine characteristics etc.) completed
3. Plan for national Training of Trainers developed
Key Achievement:
1.Training of national personnel on new EVMA tool
2. Completion of country set up on the EVMA tool
Challenges:
1. Competing activities of the Immunization Program whereby logistics personnel were involved in developing immunization strategy.
2. Human resource challenge of the national immunization program whereby minimal number are available for EVMA</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of the CCE equipment planned for year two are deployed by October 2020 At least four monthly PMT meetings conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Coordinate and monitor implementation of the CCEOP plan - Recruit a cold chain and logisitics consultant 2. Conduct Monthly PMT meeting">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
A total of 1,514 CCEOP equipment for year 2 has been received and 1,297 (86%) has been delivered to subnational level. Out of the total quantities received, 315 (21%) has been installed. For this phase of implementation, two (2) PMT meetings have been held on 2th March and 8th June 2021
Achievements:
315 (21%) of the CCE has been received and installed
Challenges:
1. Delay in the selection process for the CCEOP for year 2 due to government decision of the required model</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of all planned CCEOP equipment deployed by June 2021</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Coordinate and monitor implementation of the CCEOP plan - Recruit a cold chain and logisitics consultant

2. Conduct Monthly PMT meeting">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
Focal person for coordinating CCEOP is in place and support the project. All CCEOP (100%) for year 1 has received and installed. Performance evaluation of the suppliers conducted
Achievements:
1 Completion of country `s CCEOP phase 1
Challenges:
1. Availability of some CCE equipment with functionality problem (Total 3 equipment identified)</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Coordinate and monitor implementation of the CCEOP plan - Recruit a cold chain and logisitics consultant

2. Conduct Monthly PMT meeting">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
Focal person for coordinating CCEOP is in place and support the project. All CCEOP (100%) for year 1 has received and installed. Performance evaluation of the suppliers conducted
Achievements:
1 Completion of country `s CCEOP phase 1
Challenges:
1. Availability of some CCE equipment with functionality problem (Total 3 equipment identified)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVMA report developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Effective Vaccine Management Assessment (EVMA)">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1.Orientation of the national level personnel on the new EVMA tools conducted and completed
2. Preparation for the required set up of information on the tool (location file, vaccine characteristics etc.) completed
3. Plan for national Training of Trainers developed
Key Achievement:
1.Training of national personnel on new EVMA tool
2. Completion of country set up on the EVMA tool
Challenges:
1. Competing activities of the Immunization Program whereby logistics personnel were involved in developing immunization strategy.
2. Human resource challenge of the national immunization program whereby minimal number are available for EVMA</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Effective Vaccine Management Assessment (EVMA)">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Training of Trainers on EVM 2 completed. Plan for subnational training is ongoing and will be completed in December 2021. Fund disbursement is ongoing. Invitation of assessors and trainers completed. Sample size selected for EVMA completed. Field work data collection is planned for December 2021.EVMA report development planned for the December 2021
Challenge:
Delay due to COVID 19 pandemic and response vaccination that resulted in delay training and field work by assessors</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least one visit conducted to support EPI in Zanzibar</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Unicef Immunization Specialist to monitor implementation and provide technical support to IVD program in Tanzania mainland and Zanzibar">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
Plan for support EPI Zanzibar in place. Due to limitation for movements as a result of ongoing Covid 19 outbreak this visit delayed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NLWG (or equivalent) convened and demonstrated to be meeting regularly in past 3 months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Quantification of vaccines and CCE and quartely review of the supply plan so as to ensure there are no stock out of vaccines

3. Coordinate and monitor implementation of the CCEOP plan">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. One (1) National Logistic Technical Working (NLWG) meeting conducted on 2nd March 2021. A total of 14 members participated in the meeting that discussed EVMA, vaccine renewal, CCEOP, Logistic information system and temperature monitoring in the country. Moreover, two (2) CCEOP meetings were conducted that also discussed logistic challenges in the country
Achievements:
1. One (1) National Logistic and two (2) CCEOP meetings conducted
Challenges:
1. Availability of the MoH immunization resource personnel due to competing activities whereby the program was developing the national immunization strategy</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NLWG (or equivalent) convened and demonstrated to be meeting regularly in past 6 months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Quantification of vaccines and CCE and quartely review of the supply plan so as to ensure there are no stock out of vaccines

3. Coordinate and monitor implementation of the CCEOP plan">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Supply plan reviewed quarterly and no stock out of vaccine was observed. Two (2) logistics meetings conducted. CCEOP monitored and implementation completed. Final review of the CCEOP implementation done</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">e-Surveillance platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Strengtherning of Measles and Rubella case based surveillance and documentation of progress towards elimination">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Tanzania adopted the AFRO target of measles elimination by the year 2020. To enhance the control of measles and achieve the regional and global measles elimination goals, the Ministry of Health and partners in Tanzania reviewed the status of measles control in the country and incorporated measles elimination strategy into a comprehensive multi-year plan (c-MYP) for 2016 ? 2020. The purpose of the strategic plan was to systematically guide the planning and implementation of measles elimination activities to achieve measles elimination. 
The targets adopted for 2020 were: 
1.	Measles incidence of less than 1 case per million populations; 
2.	Maintaining 95% measles immunization coverage at national level and in all districts;
3.	Attaining 95% coverage in all scheduled measles SIAs and in response to outbreaks; and
4.	Maintaining the targets for the two main surveillance performance indicators
The strategies applied include;
1. Providing a first dose of measles containing vaccine at or shortly after the 9th month of age, ensuring that all children who missed their first dose receive a dose at the earliest possible time irrespective of their age at the time;
2. Providing a second dose of measles vaccine in the routine immunization program at 18 months of age;
3. Strengthening of Measles and Rubella case based surveillance and documentation of progress towards elimination
WHO has supported intensification of routine immunization under PIRI activities which improved uptake of second dose of MR vaccine.
WHO has supported a workshop of National verification Committee to document progress towards Measles elimination. However since 2020, Tanzania faced a big challenge on laboratory confirmation of suspected measles cases and many specimens were not tested timely. This influenced negatively the Measles rubella case based surveillance performance in Tanzania with many cases becoming compatible.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Strengtherning of Measles and Rubella case based surveillance and documentation of progress towards elimination">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">WHO has supported the country to implement activities for measles elimination. this includes support to routine immunization, conduct supplementary immunization and measles case based surveillance. 
For the year 2020, the vaccination coverage for MR1 was 99% and MR2 being 83% a drop from 88% in the year 2019. the reason was due to shortage of MR vaccine.
WHO has supported documentation of progress towards measles elimination.Tanzania NVC members and secretariate had a session at Morogoro Hotel for three days (8 -10/04/2021) for finalization of measles elimination progress report. Assessment of population immunity and progress toward elimination of measles was done through reviewing of records. The population profile of measles immunity among residents aged 0 through 19 years was developed and compared this profile to the distribution of measles cases across different age groups. 
Results: Although the country has maintained high coverage over the years, there are variations of immunization performance observed at sub-national levels with some achieved the coverage of below 90%. Additionally, despite a promising improved coverage of Measles/Rubella second dose (MR2) over years, the number of Measles/Rubella unimmunized children is still high countrywide. In the period of 2017 to 2020, Measles case-based surveillance indicators have been on track to achieve target. At national level, the country has attained Non-Measles -Non-Rubella rate (N-MR FRI Rate) of 2.0 and the number of reported suspected measles rubella cases has increased.
Recommendation and Conclusion: Measles immunity need to be increased through advocating uptake of MR2 among eligible children. The NVC still anticipate low measles immunity in both infants and children between 0 and 5 years since cases predominantly occur in these two age groups.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support, participate and facilitate in the 2020 data review and harmonization, triangulation at National, Regional and District level before completion of the WHO/UNICEF JRF">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">The process of JRF completion involves stakeholders from within MOHCDGEC-Mainland, Zanzibar, and partners. This activity was conducted in two sessions starting from 06th ? 16th April 2021. 
Session 1: Compilation of eJRF main document.
The First session was used to develop eJRF main form which was done first in the downloaded excel file which was later transferred to electronic form in the WHO portal. 
eJRF form is divided into 19 sheets which captures country administrative profile, VPD cases and surveillance, immunization country profile, Logistics and supplies, communication, immunization pogramme management, vaccination coverage and general performance. Each form was assigned to a specific group according to thematic areas. This work was later presented to plenary where inputs were received from participants. 
Source of information used was from reported administrative data in EIS, DHIS-2, Surveys reports, and other related source of information. This year, eJRF form also came with COVD-19 vaccination readiness form. For Tanzania, we did not have any response on CIVD-19 vaccine as the country is awaiting assigned technical committee?s recommendations.
Session 2: Development and Compilation of DIP and annual desk review.
Joint report form submission requires updated annual desk review analysis, Data Improvement plan, Hw?s vaccinations form.
DIP document highlight country?s plans to improve quality of routine reported data. It supposed to be updated every year.
Data desk review analysis monitors performance of routine immunization and surveillance indicators while HW?s vaccination form collects details on plans and status of vaccination to health care workers. 
These documents were finalized and shared with IVD technical working group for more inputs. 
OUTCOMES OF THIS ACTIVITY:
The team successfully managed to finalize eJRF document in country portal, which was reviewed and approved at country level and now awaits external reviews.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support, participate and facilitate in the 2020 data review and harmonization, triangulation at National, Regional and District level before completion of the WHO/UNICEF JRF">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">WHO provided technical and financial support to conduct a workshop from 13th to 15th April 2021. 
The main objective of the workshop was to harmonize immunization data for the period of January to December 2020 from TiMR, VIMS, DHIS, IDSR and other programme data and preparation of data improvement plan and annual report in electronic WHO/UNICEF joint reporting form ready for submission to WHO AFRO. 
Specific Objectives includes
?	To review the immunization data from all sources for the purpose of doing data cleaning and harmonization prior to the development of electronic JRF report 
?	To monitor that state of completeness, validity, consistency, timeliness and accuracy of surveillance and immunization coverage data at national level
?	To identify problems with data quality through a process of data cleaning and verification with respective councils and health facilities
?	To ensure the harmonization of laboratory and case-based surveillance databases 
?	Develop draft electronic JRF report and data improvement plan. 
The workshop involved all immunization stakeholders including; MoHCDGEC (IVD, HMIS, IDSR) PORALG, WHO, CHAI, JSI and representative of the Regional Immunization and Vaccine Officers (RIVOs) and Representative of the District Immunization Officers from the region (DIVOs)
Accomplished:
1.	Immunization data cleaning and harmonization exercise was successful conducted, and feedback provided to the regions and councils for future improvements on data quality. 
2.	Draft electronic WHO/UNICEF Joint Report Form for Immunization was developed based on the standard templates and guidance provided by WHO and UNICEF regional Office. 
3.	Draft Data Improvement Plan was agreed and the small team to work on the advancement of the draft was formed. The agreed timeline for the finalization of the data improvement plan is end of April before the final submission of the JRF report.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Medium-term costed strategic plan for immunisation (National Immunisation Strategy) developed by MOH/EPI and integrated with national health strategy (country-led, with a capacity building component)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Zanzibar to develop 2021-2025 National Immunization Strategy (NIS)">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">The Ministry of Health -Zanzibar needs to develop NIS/cMYP in order to ensure all the national, regional and global plans for ensuring the benefit of vaccines is achieved by all in order to attain sustainable development goals and guidance to the immunization programme is maintained.
Rationale for developing NIS/cMYP
1.	To support Ministry responsible for health in Zanzibar to define five-year goals and develop a roadmap for achieving the objectives. 
2.	The NIS will be aligned with the global IA2030 and national health strategic plan IV and it is expected that NIS will have a vision to address the immunization challenges in all target population especially for the emerging diseases and hence protect against vaccines preventable diseases. 
3.	The NIS will also be used as the advocacy tool in ensuring sustainable vaccination services.
4.	Lastly, the tool will be used to secure resources for promoting immunization services both domestically and internationally. 
There has been a major delay in developing this strategy due to competing priorities especially those related to responding to COVID-19 outbreak. 
With the support of consultant, the development of the NIS will be done through the programme documents review and national dialogues (workshops/meetings) with stakeholders in each of the following stages;
a)	Situational analysis and EPI review
b)	Setting goals, objectives, strategies and roadmap for action
c)	Identify resources requirement and advise the Ministry responsible for health to conduct budget negotiation for the developed strategy
d)	Developing monitoring and evaluation system
e)	Approval and endorsement of NIS</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation-related planning priorities and resource needs reflected in the national health plan and budget/medium-term expenditure frameworks</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Zanzibar to develop 2021-2025 National Immunization Strategy (NIS)">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">WHO is supporting Zanzibar to develop its own NIS. There has been a delay in conducting the activity due to delay in finalizing the NIS for Tanzania mainland. The concept note has been submitted and EPI programme review will be conducted while formal engagement of consultant to support the activity is being formalized</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation report sharing experiences with the urban immunization approach available.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct training and support bottleneck analysis for delivering immunization services in urban areas (DSM and Unguja) and planning process using REC approach.">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Activity not started due to COVID-19 situation in Dar es salaam region. Planned to be conducted before September 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct training and support bottleneck analysis for delivering immunization services in urban areas (DSM and Unguja) and planning process using REC approach.">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Activity not started due to COVID-19 situation in Dar es salaam region. Planned to be conducted before September 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct training and support bottleneck analysis for delivering immunization services in urban areas (DSM and Unguja) and planning process using REC approach.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Dar es Salaam region is providing immunization services in all districts with the view to improving access and quality immunization services to every eligible child. By implementing the comprehensive council plans with components of delivering immunization services, every council is expected to attain immunization coverage of 90% or more of all antigens. 
Though the national EPI programme adopted the RED/REC approach since many years ago, not all the districts are able to achieve the expected 90% or more coverage every year. A review of immunization coverage data from 2015 to 2020 shows that between 10-30% of targeted children (0-11 months) do not receive their third dose of penta3 annually. The districts mostly affected with large number of under vaccinated with MR2 children for the year 2020 are Temeke (6126), Ilala (6094) and Kinondoni (4756). There are also high immunization dropout (penta1-penta3) rates in these same districts that account for low coverage (Source DSM Annual EPI data 2015-2020). 
 There is also significant population movement in cities; slum populations and other people living in poverty in urban areas can be particularly fluid with considerable in and out-migration. Poor urban dwellers and slum populations can also be particularly diverse in comparison with more stable rural populations, leading to additional challenges in social cohesion, communication and health seeking behavior. For these reasons, existing RI assessment mechanisms require adaptation or possible replacement to work effectively in impoverished urban settings. The concerns about the persistent low immunization coverage in 3 councils of DSM generated interests for rapid assessments of the immunization programme in DSM in collaboration with the EPI programme in selected districts to understand the reasons for poor immunization performance and plan for improvement. 
There has been major delay in implementing this activity due to intense transmission of COVID-19 in DSM</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Progress report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct training and support bottleneck analysis for delivering immunization services in urban areas (DSM and Unguja) and planning process using REC approach.">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">There has been major delays due to COVID-19 outbreak especially in Dar es salaam and Unguja, urban areas targeted for the activity. we hope to conduct the activity soon</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Measles Elimination progress report available and submitted to WHO AFRO</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support strengthening of Measles rubella case based surveillance activities and documentation of progress towards elimination.">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Tanzania National Verification Committee members and secretariat had a session at Morogoro Hotel for three days (8 -10/04/2021) for finalization of measles elimination progress report. Assessment of population immunity and progress toward elimination of measles was done through reviewing of records. The population profile of measles immunity among residents aged 0 through 19 years was developed and compared this profile to the distribution of measles cases across different age groups. 
Results: Although the country has maintained high coverage over the years, there are variations of immunization performance observed at sub-national levels with some achieved the coverage of below 90%. Additionally, despite a promising improved coverage of Measles/Rubella second dose (MR2) over years, the number of Measles/Rubella unimmunized children is still high countrywide. In the period of 2017 to 2020, Measles case-based surveillance indicators have been on track to achieve target. At national level, the country has attained Non-Measles -Non-Rubella rate (N-MR FRI Rate) of 2.0 and the number of reported suspected measles rubella cases has increased.
Recommendation and Conclusion: Measles immunity need to be increased through advocating uptake of MR2 among eligible children. The NVC still anticipate low measles immunity in both infants and children between 0 and 5 years since cases predominantly occur in these two age groups.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support strengthening of Measles rubella case based surveillance activities and documentation of progress towards elimination.">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Tanzania National Verification Committee members and secretariat had a session at Morogoro Hotel for three days (8 -10/04/2021) for finalization of measles elimination progress report. Assessment of population immunity and progress toward elimination of measles was done through reviewing of records. The population profile of measles immunity among residents aged 0 through 19 years was developed and compared this profile to the distribution of measles cases across different age groups. 
Results: Although the country has maintained high coverage over the years, there are variations of immunization performance observed at sub-national levels with some achieved the coverage of below 90%. Additionally, despite a promising improved coverage of Measles/Rubella second dose (MR2) over years, the number of Measles/Rubella unimmunized children is still high countrywide. In the period of 2017 to 2020, Measles case-based surveillance indicators have been on track to achieve target. At national level, the country has attained Non-Measles -Non-Rubella rate (N-MR FRI Rate) of 2.0 and the number of reported suspected measles rubella cases has increased.
Recommendation and Conclusion: Measles immunity need to be increased through advocating uptake of MR2 among eligible children. The NVC still anticipate low measles immunity in both infants and children between 0 and 5 years since cases predominantly occur in these two age groups.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation report sharing experiences with zero dose tracking approach to improve immunization coverage available.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support mapping of zero dose MCV1 (unvaccinated) children and identify reasons and support to improve coverage of measles second dose - SSA  officer to be embedded in IVD for 60% of the time and WHO office 40%">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">This report has not been completed</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support mapping of zero dose MCV1 (unvaccinated) children and identify reasons and support to improve coverage of measles second dose - SSA  officer to be embedded in IVD for 60% of the time and WHO office 40%">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">This report has not been completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">25 of un(der)immunized children are located through community relays and door to door approaches</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identification of Zero Dose children in routine immunization services using Community Health Workers (CHWs) in urban communities">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Implementing partner for identification of zero dose children identified. Tools and SOP for the identification of Zero dose children identification completed. Funds disbursement to the region completed. Field work Implementation is ongoing
Challenge:
The outbreak of COVID 19 and response vaccination resulted in diversion of focus to response for routine vaccine services by the government and implementing partner. This has has resulted in delay of the partner implementation of identification of zero dose children for routine immunization</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identification of Zero Dose children in routine immunization services using Community Health Workers (CHWs) in urban communities">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. Standard Operating procedure and tools for identification of Zero Dose children by Community Health Workers Developed
2. Endorsement of SOP and tools by the immunization technical working group done. Further orientation of the tool and will be done in July to subnational level before dissemination
Achievement:
1. Development of tools and SOP for identification of zero dose children by CHWs</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Academic staff of selected training institution received TOP training and IPC training curriculum developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Coordinate, collaborate and facilitate evidence based immunization and RMNCH C4D
planning, implementation, monitoring and evaluation and influence policy and
practice  at national and sub-national
levels  

2. Provide technical support to low performing
districts and health facilities to improve interpersonal communication and
community engagement for immunization and RMNCH services                                              

3. Provide technical support in designing and development of communication plan/messages
for MR campaign and new vaccine introductions; and

4. Engage in C4D activities for sustenance of
routine immunization.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. The interpersonal communication training package was developed and pre-tested to an audience similar to that targeted by the package .Improvement was done according to the noted observations and feedback and finalized
2. The Interpersonal communication TOT training was conducted to 40 academic staff from 15 training institutions including universities, collages and zonal training centres utilizing the developed interpersonal communication training package.
Achievements:
1. Development and finalization of IPC training package
2. Conduct IPC TOT training to 40 academic staff from selected training institutions
Challenges:
1. COVID 19 restrictions that caused delay and missing some targeted participants and facilitators.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Coordinate, collaborate and facilitate evidence based immunization and RMNCH C4D
planning, implementation, monitoring and evaluation and influence policy and
practice  at national and sub-national
levels  

2. Provide technical support to low performing
districts and health facilities to improve interpersonal communication and
community engagement for immunization and RMNCH services                                              

3. Provide technical support in designing and development of communication plan/messages
for MR campaign and new vaccine introductions; and

4. Engage in C4D activities for sustenance of
routine immunization.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Progress:
1. The interpersonal communication training package was developed and pre-tested to an audience similar to that targeted by the package .Improvement was done according to the noted observations and feedback and finalized
2. The Interpersonal communication TOT training was conducted to 40 academic staff from 15 training institutions including universities, collages and zonal training centres utilizing the developed interpersonal communication training package.
Achievements:
1. Development and finalization of IPC training package
2. Conduct IPC TOT training to 40 academic staff from selected training institutions
Challenges:
1. COVID 19 restrictions that caused delay and missing some targeted participants and facilitators.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of un(der)immunized children are located through community relays and door to door approaches</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identification of Zero Dose children in routine immunization services using Community Health Workers (CHWs) in urban communities">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Zero dose identification tools and SOP developed; shared with the implementing partners. Fund disbursement done. Identification of the zero dose children is ongoing
Challenge:
Delay in implementation due to COVID 19 pandemic and vaccination response. Much of the effort was directed towards the pandemic and this resulted in delay in implementation by partner</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IVD and M&amp;E focal persons in each of the region that has transitioned into completely paperless empowered to conduct 2 targeted supportive supervision &amp; mentorship based on performance data and able to address all issues in each of the region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE1: Support and build the capacity of the MOHCDGEC ICT, monitoring and evaluation (M&amp;E), and IVD programs in transitioning into completely paperless data collection, processing, and reporting from the PHC to the national levels.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MOH ? ICT team is able to do routine TimR software management (administration, server performance and bug fixing) and customization of current and new features as will be required.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE3: Build the capacity of the MOHCDGEC ICT in-house development team in TimR software maintenance and customization.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Four regions of Tanzania mainland transitioned into completely electronic data collection system from health facility to national level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE1: Support and build the capacity of the MOHCDGEC ICT, monitoring and evaluation (M&amp;E), and IVD programs in transitioning into completely paperless data collection, processing, and reporting from the PHC to the national levels.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Enhanced TimR software with immunization inequity indicators deployed in prioritized district (s) by MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE2: Enhance the ability of the TimR system to routinely collect, analyze, and report data related to factors leading to immunization inequities, such as mother?s education, income level, distance from facility or outreach post, and the family?s place of residence.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National Strategy and Guideline for integration of CRVS birth registration and Immunization program developed and  disseminated to government and partners to inform scale up and resource mobilization</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE4: Provide technical capacity and linkages of the TimR system and the country?s CRVS system for improved denominator of the children to be immunized.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data quality and use guide disseminated to immunization manager across all level of health information system for use</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE5: Support the MOHCDGEC mainland (M&amp;E and IVD programs) to develop and institutionalize data use accountability on immunization data from the PHC to the national levels for improved coverage and equity.">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Publication on contribution of and attribution of TimR in immunization data quality, use and coverage and equity
Publication on outcome of CRVS birth registration and Immunization program on denominator and immunization coverage</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE7: Support the MOHCDGEC in documentation and publication of lessons learned and best practices on existing and emerging issues related to the implementation of the TimR system and data use interventions.">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EIS solution is deployed in 50% of health facilities and district providing immunization service in Zanzibar

Internal evaluation of EIS solution implementation and immunization performance outcome is implemented.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE6: Support and build the capacity of the Ministry of Health of Zanzibar in customization and implementation of the EIS for improved coverage and equity.">
      <location ref="TZ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Strengthening of routine immunization with focus on increasing uptake of MCV2 vaccine">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">WHO is support MoH to strengthen routine immunization especially in low performing district. The activity was launched by the Minister of health during African vaccination week on 27th April 2021. 
Overall Objective
The overall objective is to support low performing councils to identify key challenges for low performance and strengthen routine immunization through implementation of PIRI.
Specific Objectives
1.	To identify low performing councils based on routine data, coverage survey and MR zero dose collected during 2019 IMRC.
2.	To identify key challenges for relatively low immunization performance in the respective council
3.	To set and implement strategies (including PIRI) to address the key identified challenges
?	Identification of the Low performing councils
The country aimed at identifying the lower preforming councils (based on both routine data, coverage survey data and MR zero dose data collected during 2019 IMRC) and assess the reason for low performance and implement high impact interventions with the use of PIRI. The map below shows the low performing councils.
?	Identification of Challenges and Set Strategy 
Although the aim of the support is to implement PIRI approach, but other strategies will be set based on the key identified challenges in a specific region/council. The team from National and Regional level will facilitate the process of setting strategy and the councils and health facility levels will be fully involved to ensure the set strategy are realistic and implementable. The developed tools will be used to assess the gaps in key immunization thematic areas (including; Planning and Management, Service delivery, Demand creation and Social Mobilization and Data Management) areas which will guide the set strategy.
The implementation of the identified strategic actions will be tailored to the council moreover all councils identified will implement PIRI.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support mapping of Zero dose children and set strategies to vaccinate all eligible children in selected regions-SSA officer to be embedded in IVD for 60% of the time and WHO office 40%">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">WHO supported the MoH in conducting data desk review for 2020 district performance data and identify areas will large number of unvaccinated children.
The number of Measles/Rubella under-vaccinated children has increased from 233,304 in 2019 to 357,534 in 2020, an increment of 53% . There was huge variation on Measles/Rubella under-vaccinated children across districts in 2020 whereby 18 districts had more than 5000 Measles/Rubella under-vaccinated children . This has increased from 7% in 2019 to 9% in 2020.
The number of districts with MCV1 coverage below 80% increased from 9 (5%) districts in 2019 to 16 (8%) districts in 2020. Further, the number of districts with MCV1 coverage of 90% or above dropped from 157 (81%) districts in 2019 to 153 (78%) districts in 2020. This can be attributed by inconsistency availability of MR vaccines across the districts.
All the identified districts were targeted for PIRI during African vaccination week and beyond. Tools have been prepared, printed and disseminated to all targeted districts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Strengthening of routine immunization with focus on increasing uptake of MCV2 vaccine">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">In 2014, Tanzania introduced MCV2 given at the age of 18 months into the Routine immunization and in 2018. There are several initiatives led by the Ministry of Health through the support of partners including Gavi, WHO, UNICEF, CHAI, JSI, Jhpiego, PATH and others to strengthen immunization system and address the key challenges identified by the program. The initiatives include; Introduction of Electronic Immunization System, improving Warehouse Management of Vaccines and related supplies at National and subnational levels, capacity building of health workers on different key thematic areas and provision of technical support in implementation of various activities.
Given the fact that Tanzania has maintained high vaccination coverages over the years and the fact that some of the regions and councils are not performing well based on the administrative data and Periodic Intensification of routine immunization in these scenarios is necessary to boost routine coverage. It is also important for the country to identify key challenges for low performance and set and implement strategies to address the identified challenges. The overall objective is to support low performing councils to identify key challenges for low performance and strengthen routine immunization through implementation of PIRI.
Specific Objectives
1.	To identify low performing councils based on 2020 routine immunization coverage data, coverage survey and MR zero dose collected Measles rubella case based surveillance and estimated of children unvaccinated with second dose of MCV.
2.	To identify key challenges for relatively low immunization performance in the respective council
3.	To set and implement strategies (including PIRI) to address the key identified challenges
Methodologies
?	Identification of the Low performing councils
?	Identification of Challenges and Set Strategy 
?	Implementation and Monitoring &amp; Evaluation
The total budget for the activity is equivalent to US$132,762</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support mapping of Zero dose children and set strategies to vaccinate all eligible children in selected regions-SSA officer to be embedded in IVD for 60% of the time and WHO office 40%">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MOH ICT team enabled to perform customization of TimR software back end independently from PATH support</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE3: Build the capacity of the MOHCDGEC ICT in-house development team in TimR software maintenance and customization.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">Since 2018, PATH through TCA have been training the MOH ICT team on TimR software management including integration with other system, hosting and infrastructure management as well as software customization. However, the training and capacity building initiative have not translated into the team taking active role in supporting software management roles. In Q2 this year, MOH ICT team hired and seconded four staff with software administration and management skillsets to provide support to IVD electronic information systems (EIS). Path has been actively working with the team to building their capacity of TimR software management through trainings, mentorship and engagement into ongoing customization activities. The team is apparently able and is managing all software administrative and infrastructure management roles which is key for total ownership of the TimR solution .</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IVD and M&amp;E focal persons at national and subnational level empowered to conduct 2 targeted supportive supervision &amp; mentorship based on performance data and able to address all issues</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE1: Support and build the capacity of the MOHCDGEC ICT, monitoring and evaluation (M&amp;E), and IVD programs in transitioning into completely paperless data collection, processing, and reporting from the PHC to the national levels.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE1: Support and build the capacity of the MOHCDGEC ICT, monitoring and evaluation (M&amp;E), and IVD programs in transitioning into completely paperless data collection, processing, and reporting from the PHC to the national levels.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Two regions of Tanzania mainland transition into complete electronic data collection system from health facility to national level.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE1: Support and build the capacity of the MOHCDGEC ICT, monitoring and evaluation (M&amp;E), and IVD programs in transitioning into completely paperless data collection, processing, and reporting from the PHC to the national levels.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE1: Support and build the capacity of the MOHCDGEC ICT, monitoring and evaluation (M&amp;E), and IVD programs in transitioning into completely paperless data collection, processing, and reporting from the PHC to the national levels.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data quality and use guide developed, reviewed and disseminated to MOH management and relevant partners; Capacity building to national and regional team on use of data use guide to mentor health care workers.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE5: Support the MOHCDGEC mainland (M&amp;E and IVD programs) to develop and institutionalize data use accountability on immunization data from the PHC to the national levels for improved coverage and equity.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE5: Support the MOHCDGEC mainland (M&amp;E and IVD programs) to develop and institutionalize data use accountability on immunization data from the PHC to the national levels for improved coverage and equity.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Publication on outcome of transition from paper to electronic data collection and management system in immunization program</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE7: Support the MOHCDGEC in documentation and publication of lessons learned and best practices on existing and emerging issues related to the implementation of the TimR system and data use interventions.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE7: Support the MOHCDGEC in documentation and publication of lessons learned and best practices on existing and emerging issues related to the implementation of the TimR system and data use interventions.">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MOH ICT team  enabled to perform customization of TimR software back end independently from PATH support</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE3: Build the capacity of the MOHCDGEC ICT in-house development team in TimR software maintenance and customization.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE3: Build the capacity of the MOHCDGEC ICT in-house development team in TimR software maintenance and customization.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Integration of BRS4G and TimR implemented and demonstrated at scale in one region selected by MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE4: Provide technical capacity and linkages of the TimR system and the country?s CRVS system for improved denominator of the children to be immunized.">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
      <comment>
       <narrative xml:lang="EN">The team was able to identify and document the requirements for the integration and testing was done but during the testing, it was realized that RITA made some changes that also will need to be impacted in TImR for integration to function better. So those changes were identified, PATH team with IVD technical team are currently working on accommodating those new changes, after those changes are implemented RITA technical team and IVD will meet for another round of testing, after testing is completed it will be demonstrated to IVD and RITA management team before testing to Health facilities. 
Finalization of preparations and demonstration in one district in Morogoro region is ongoing and has been planned to take place not later than January 2022. Morogoro was selected as a test site to easy the process of providing support when needed as well as the fact that both TImR and Under-five birth Registration system are in place with reasonable degree of usability and maturity.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE4: Provide technical capacity and linkages of the TimR system and the country?s CRVS system for improved denominator of the children to be immunized.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE4: Provide technical capacity and linkages of the TimR system and the country?s CRVS system for improved denominator of the children to be immunized.">
      <location ref="TZ"></location>
     </target>
     <actual value="Major Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Publication on experience and lessons learnt in integrating of CRVS and Immunization program in Tanzania; Publication on lessons and experience of inclusion of immunization equity indicators in routine data collection through TimR</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE7: Support the MOHCDGEC in documentation and publication of lessons learned and best practices on existing and emerging issues related to the implementation of the TimR system and data use interventions.">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Integration of Birth Registration System 4th Generation (BRS4G) and TimR system piloted in one district selected by MOH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE4: Provide technical capacity and linkages of the TimR system and the country?s CRVS system for improved denominator of the children to be immunized.">
      <location ref="TZ"></location>
     </target>
     <actual value="On Track">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National TOT team for Zanzibar trained on using and supporting EIS system</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE6: Support and build the capacity of the Ministry of Health of Zanzibar in customization and implementation of the EIS for improved coverage and equity.">
      <location ref="TZ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="OBJECTIVE6: Support and build the capacity of the Ministry of Health of Zanzibar in customization and implementation of the EIS for improved coverage and equity.">
      <location ref="TZ"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All communication contents related to safe operation of immunization services during COVID -19 pandemic developed for dissemination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to MOH in development of communication materials including SMS massaging, mass media content related to maintaining safe immunization services particularly during outbreak">
      <location ref="TZ"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Jhpiego : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% fully vaccinated girls in catchment area of new sites in 6 District Councils in Njombe Region 30-40% HPV vaccination coverage through facility based integrated ARSH and HPV services in Njombe Region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV Plus services with MOHCDGEC/PORALG utilizing lessons learned from demonstration sites. Activities include: training HCP in high volume sites, engaging community leaders for demand creation, outreach services, facilitating district level supportive supervision, and data review meetings">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% fully vaccinated girls in catchment area of new sites in 6 District Councils in Njombe Region

30-40% HPV vaccination coverage through facility based integrated ARSH and HPV services in Njombe Region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implement HPV Plus services with MOHCDGEC/PORALG utilizing lessons learned from demonstration sites. Activities include: training HCP in high volume sites, engaging community leaders for demand creation, outreach services, facilitating district level supportive supervision, and data review meetings">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Covid-19 digital package installed">
      <location ref="TZ"></location>
     </target>
     <actual value="Completed">
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5.EPI Legacy data migrated (if fully transitioned)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Rocque Advisory : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Quarterly report with updates of the progress of implementation of activities of the project</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support staff of the Immunisation and Vaccine Development Department (?IVD?) and the Ministry of Health (?MOH?) to ensure a high level of implementation and funds absorption, and proper accountability for Gavi provided funds.">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support staff of the Immunisation and Vaccine Development Department (?IVD?) and the Ministry of Health (?MOH?) to ensure a high level of implementation and funds absorption, and proper accountability for Gavi provided funds.">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support staff of the Immunisation and Vaccine Development Department (?IVD?) and the Ministry of Health (?MOH?) to ensure a high level of implementation and funds absorption, and proper accountability for Gavi provided funds.">
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Rocque Advisory : Programme Management - Financial Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Quarterly report with updates of the progress of implementation of activities of the project</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="TZ"></location>
     </target>
     <actual>
      <location ref="TZ"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
